Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-640-9 | CAS number: 26381-41-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
LD50 was considered to be between 2000 and 4000 mg/kg bw when CYF male and female rats were treated with Basic Brown 16. Therefore, Basic Brown 16 cannot be classified as per the criteria of CLP regulation for acute oral toxicity.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- other: Data is from opinions on health and safety risks (chemical, biological, mechanical and other physical risks)
- Qualifier:
- according to guideline
- Guideline:
- other: refer below principle
- Principles of method if other than guideline:
- Study conduct to determine the acute toxic effects by oral route of test substance Basic Brown 16 in male and female CFY rat.
- GLP compliance:
- no
- Test type:
- other: no data
- Limit test:
- no
- Species:
- rat
- Strain:
- other: CFY
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No data available
- Route of administration:
- oral: gavage
- Vehicle:
- other: methylcellulose
- Details on oral exposure:
- VEHICLE- Concentration in vehicle:0, 0.1, 1.0, 2.0 and 4.0 g/kg bw in volumes of 1.0 to 40 ml/kg- Amount of vehicle (if gavage):40 ml/kg
- Doses:
- 0, 0.1, 1.0, 2.0 and 4.0 g/kg bw
- No. of animals per sex per dose:
- 2 male + 2 female rats
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days - Frequency of observations and weighing:daily- Necropsy of survivors performed: no- Other examinations performed: mortality and clinical abnormalities,Body weights and macroscopic observations.
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 000 - 4 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- There were no mortalities
- Clinical signs:
- other: Signs of reaction to treatment, observed shortly after dosing, included piloerection and abnormal body carriage (hunched posture).
- Gross pathology:
- No abnormalities were recorded at autopsy.
- Interpretation of results:
- not classified
- Remarks:
- Migrated informationCriteria used for interpretation of results: EU
- Conclusions:
- The LD50 was reported to be between 2000 and 4000 mg/kg bw.
- Executive summary:
Groups of 2 male and 2 female rats received a single oral dose of 0.1, 1.0, 2.0 or 4.0 g/kg bw. Control animals received 1% aqueous methylcellulose in a volume of 40 ml/kg. The animals were observed daily for 14 days for mortality and clinical abnormalities. Body
weights and macroscopic observations were recorded, but histological examinations were not performed.
Within one week of dosing, all animals treated at 4.0 g/kg bw died, one female died after a dose of 1.0 g/kg and one after a dose of 2.0 g/kg bw; no male rats died at doses of 1 or 2 g/kg bw. There were no mortalities at 0.1 g/kg. Signs of reaction to treatment, observed shortly after dosing, included piloerection and abnormal body carriage (hunched posture). The bodyweight gain of surviving treated animals was similar to controls and no abnormalities were recorded at autopsy.
The LD50 was reported to be between 2000 and 4000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Available data is from Scientific Committee on Consumer Safety report for Basic Brown 16 (2012) and from the klimisch rating 4 for both target and its read across
Additional information
Acute oral toxicity:
In a opinion given by Scientific Committee on Consumer Safety for Basic Brown 16 (2012), a study report by COLIPA given acute oral toxicity on CYF male and female rats by using Basic Brown 16 in the concentration of 0, 100, 1000, 2000 and 4000 mg/kg bw in 1 % methylcellulose orally by gvage and observed for 14 days. Within one week of dosing, all animals treated at 4000 mg/kg bw died, one female died after a dose of 1000 mg/kg and one after a dose of 2000 mg/kg bw; no male rats died at doses of 1000 and 2000 mg/kg bw. There were no mortalities at 100 mg/kg. Signs of reaction to treatment, observed shortly after dosing, included piloerection and abnormal body carriage (hunched posture). The body weight gain of surviving treated animals was similar to controls and no abnormalities were observed at autopsy. Therefore, LD50 was considered to be between 2000 and 4000 mg/kg bw when CYF male and female rats were treated with Basic Brown 16.
Similar to above reference, in 2003, a study report by COLIPA given acute oral toxicity on CF-1 male mice by using Basic Brown 16 in the concentration of 5010, 6310, 7940 and 10000 mg/kg bw in distilled water by oral gavage and observed for 7 days. 9 animals were died at 10000 mg/kg bw, 5 at 7900 mg/kg bw and 1 at 6310 mg/kg bw. Decrease activity, increased respiratory rate and tremors were observed in treated mice. Therefore, LD50 was considered to be 7800 mg/kg bw when CF-1 male mice were treated with Basic Brown 16.
Similar to above reference, in 2011 for read across Basic Red 76, acute oral study was carried in Wistar male and female rats by using Basic Red 76 administered by oral gavage to a group of three male and female rats at 2000 mg/kg bw and observed for day 15. No mortality occurred. Hunched posture was noted in one female and 3 male on day 1. Red staining of the back and/or snout and/or head was noted in 1 female and 2 male between days 1 and 11. Red and/or yellow faeces and/or yellow urine were seen among the animals on days 2 and/or 3. The mean body weight gain over the study period was considered to be normal. No abnormalities were found at macroscopic post mortem examination of the treated male and female rats. Therefore, LD50 was considered to be greater than 2000 mg/kg bw when Wistar male and female rats were treated with Basic Red 76 orally.
Similar to above reference, in 2003 for read across Basic Red 76, acute oral study was carried in CFY male and female rats by using Basic Red 76. Groups of 2 male and 2 female rats received a single oral dose of Arianor Madder Red at a dose range from 100 to 16000 mg/kg bw. Control animals received vehicle alone. The animals were observed for 14 days for mortality and clinical abnormalities. Body weights and macroscopic observations were recorded, but histological examinations were not performed. No mortalities were reported in treated rats. Signs of reaction to treatment included lethargy, piloerection, decreased respiratory rate and abnormal body carriage (hunched posture). Red staining of the urine and faeces was observed at 8000 and 16000 mg/kg body weight. Therefore, LD50 was considered to be greater than 16000 mg/kg bw when CFY male and female rats were treated with Basic Red 76 orally.
Similar to above reference, in 2003 for read across Basic Red 76, acute oral study was carried on CF1 male mice by using Basic Red 76. Groups of 3 male mice received a single oral dose of Basic Red 76 at dose levels of 1000, 2510 and 5010 mg/kg bw, 10 male mice received the top dose of 10000 mg/kg bw. The animals were observed for 14 days for mortality and clinical abnormalities. Body weights and macroscopic observations were recorded, but histological examinations were not performed. No mortalities were observed. Following treatment lethargy and breathing disorders were observed in mice at 10000 mg/kg bw only. Therefore, LD50 was considered to be greater than 10000 mg/kg bw when CF1 male mice were treated with Basic Red 76 orally.
Similar to above reference, in 2003 for another read across Basic brown 17, CFY male/female rats were exposed orally to Basic brown 17 in the concentration of 0, 100, 1000, 4000, 8000 and 16000 mg/kg body weight. The test compound was prepared as 10 and 40 % (w/v) suspensions in 1% aqueous methylcellulose. Signs or reaction to treatment, observed shortly after dosing, included lethargy, piloerection, decreased respiratory rate and abnormal body carriage (hunched posture). Mortality was observed in 2 male rats and 1 female rat in 16000 mg/kg body weight. Therefore, LD50 was considered to be between 8000 and 16000 mg/kg bw when CFY male/female rats were treated with Basic brown 17.
Similar to above reference, in 2003 for another read across Basic brown 17, CF1 male mouse were exposed orally to Basic brown 17 in the concentration of 1000, 2510 and 5010 mg/kg bw administered at a volume of 0.2 ml/10 g body weight and observed for 7 days. No mortalities were observation in treated mice. Therefore, LD50 was considered to be greater than 5000 mg/kg bw when CF1 male mouse were treated with Basic brown 17.
Thus, based on the basis of available values for target Basic Brown 16 (26381 -41 -9) and two read across Basic Red 76 (CAS no. 68391 -30 -0) and Basic brown 17 (CAS no. 68391 -32 -2), it can be concluded that the substance cannot be classified as per the criteria of CLP regulation for acute oral toxicity. Available data is from Scientific Committee on Consumer Safety report for Basic Brown 16 (2012) and from the klimisch rating 4 for both target and its read across.
Justification for selection of acute toxicity – oral endpoint
The LD50 was reported to be between 2000 and 4000 mg/kg bw. and the study is resent
Justification for classification or non-classification
it can be concluded that the substance Basic Brown 16 and two read across Basic Red 76 and Basic brown 17
cannot be classified as per the criteria of CLP regulation for acute oral toxicity. Available data is from Scientific Committee on Consumer Safety report for Basic Brown 16 (2012) and from the klimisch rating 4 for both target and its read across.Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.